Breathe BioMedical develops breath analysis technology for lung cancer screening. Their LISA™ platform enables fast, precise biomarker detection, paving the way for point-of-care diagnostic tools.
Breathe BioMedical develops breath analysis technology for lung cancer screening. Their LISA™ platform enables fast, precise biomarker detection, paving the way for point-of-care diagnostic tools.